Project Grant W911QY1510001

The Department of Defense's Military Medical Research and Development program (CFDA 12.420) awarded Xplosafe LLC a $500,000 project grant on September 15, 2023. The grant supports Xplosafe's efforts to develop innovative monitoring solutions for assessing environmental and personal exposures to hazardous chemicals. Key objectives include transforming battlefield health care and improving environmental chemical detection capabilities. Xplosafe, a provider of critical safety solutions, will...

This cooperative agreement, awarded by the Department of the Army Materiel Command Research Development and Engineering Command (RDECOM), supports the development of an advanced microwave-activated microporous material sensor for enhanced chemical threat detection in military helmets. The research is funded under the Department of Defense Basic Scientific Research program (CFDA 12.431), which aims to advance fundamental knowledge and technological capabilities with potential military...

This Project Grant from the Defense Threat Reduction Agency provides $668,000 in funding under the Scientific Research - Combating Weapons of Mass Destruction federal grant program (CFDA 12.351) to support fundamental research to counter weapons of mass destruction. Specifically, the University of California, Berkeley will utilize molecular dynamics simulations to understand how random heteropolymers arrange within and around metal organic frameworks and provide functions such as stabilizing...

The Department of the Army Medical Command has awarded a $5,468,175 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to the University of Utah to develop a sustained-release drug delivery device to manage biofilm implant-related infections. The project, with a performance period from May 1, 2024 to April 30, 2028, will involve the University of Utah collaborating with Purgo Scientific LLC as a sub-awardee to advance this innovative medical technology. The...

Federal Project Grant Award Summary Georgia TECH Research Corp received a $336,101 Project Grant from the Defense Threat Reduction Agency (DTRA) under the Scientific Research - Combating Weapons of Mass Destruction program (CFDA 12.351) on March 9, 2026, with a completion date of March 8, 2031. The multidisciplinary research initiative is designed to advance knowledge and improve capabilities for developing new or improved medical countermeasures (MCMs) against chemical and biological threats...

Federal Project Grant Award Summary The Defense Threat Reduction Agency (DTRA) awarded Battelle Memorial Institute a $508,306.42 Project Grant under the Scientific Research - Combating Weapons of Mass Destruction program (CFDA 12.351) effective February 9, 2026, through February 8, 2031. This award supports the development and refinement of a novel polymeric/protein nanoparticles (PNP) platform designed to deliver episomal DNA constructs containing tetracycline-inducible promoters for...

Theradaptive Inc. was awarded a $3,979,465 Project Grant from the Department of the Army Medical Command on September 15, 2022 to complete the project by September 14, 2024. The grant was awarded under the Military Medical Research and Development program (CFDA 12.420), which supports biomedical research to transform military and public health care through innovative solutions for battlefield medicine. Specifically, the funding will support Theradaptive's development of a sustained release...

This $2,826,619 federal Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) funds research at the University of North Carolina at Chapel Hill to develop a sublingual formulation of dexmedetomidine for the prevention and reduction of Acute Stress Response Syndrome (ASRS), Autism Spectrum Disorder (ASD), and Post-Traumatic Stress Disorder (PTSD) in order to sustain warfighter performance. The research project...

Federal Grant Award Summary Athena Vector Technology LLC received a $330,363 Project Grant award from the Department of Defense Medical Command, effective January 5, 2026 through January 4, 2029, under the Pest Management and Vector Control Research program (CFDA 12.355). The award supports research and development efforts to commercialize a mechanical mode of action insecticide designed for effective tick and arthropod control, with the ultimate objective of mitigating vector-borne pathogen...

Spinethera Inc. was awarded a $4,970,750.90 Project Grant from the Defense Health Agency to conduct GLP toxicology testing and Phase 2/3 development for a nonopioid, injectable drug product for the treatment of lumbosacral radiculopathy, also known as sciatica. This work will be carried out under the Military Medical Research and Development program (CFDA 12.420), which supports biomedical research to transform military and public health care through innovative and impactful investigations....